Retirement Systems Of Alabama Bristol Myers Squibb CO Transaction History

Retirement Systems Of Alabama

$25.6 Billion
Q2 2024

A detailed history of Retirement Systems Of Alabama transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Retirement Systems Of Alabama holds 1,506,791 shares of BMY stock, worth $80.1 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

1,506,791

Previous 1,366,217 10.29%

Holding current value

$80.1 Million

Previous $74.1 Million 15.54%

% of portfolio

0.24%

Previous 0.29%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$40.25 - $52.99 $5.66 Million - $7.45 Million	140,574 Added 10.29%	1,506,791 $62.6 Million
Q1 2024 Apr 30, 2024	BUY	$47.98 - $54.4 $31,570 - $35,795	658 Added 0.05%	1,366,217 $74.1 Million
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $3.18 Million - $3.79 Million	65,492 Added 5.04%	1,365,559 $70.1 Million
Q3 2023 Nov 06, 2023	SELL	$57.89 - $64.73 $295,586 - $330,511	-5,106 Reduced 0.39%	1,300,067 $75.5 Million
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $9.62 Million - $10.7 Million	-150,963 Reduced 10.37%	1,305,173 $83.5 Million
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $3.83 Million - $4.34 Million	58,297 Added 4.17%	1,456,136 $101 Million
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $1.92 Million - $2.28 Million	-28,085 Reduced 1.97%	1,397,839 $101 Million
Q3 2022 Nov 04, 2022	SELL	$0.13 - $76.84 $31,861 - $18.8 Million	-245,085 Reduced 14.67%	1,425,924 $101 Million
Q2 2022 Aug 03, 2022	SELL	$72.62 - $79.98 $3.7 Million - $4.08 Million	-50,994 Reduced 2.96%	1,671,009 $129 Million
Q1 2022 Apr 20, 2022	SELL	$61.48 - $73.72 $816,024 - $978,485	-13,273 Reduced 0.76%	1,722,003 $126 Million
Q4 2021 Jan 20, 2022	SELL	$53.63 - $62.52 $1.48 Million - $1.73 Million	-27,617 Reduced 1.57%	1,735,276 $108 Million
Q3 2021 Nov 03, 2021	SELL	$59.17 - $69.31 $3.2 Million - $3.75 Million	-54,082 Reduced 2.98%	1,762,893 $104 Million
Q2 2021 Jul 21, 2021	SELL	$61.91 - $67.42 $1.14 Million - $1.25 Million	-18,493 Reduced 1.01%	1,816,975 $121 Million
Q1 2021 Apr 15, 2021	SELL	$59.34 - $66.74 $4.17 Million - $4.69 Million	-70,240 Reduced 3.69%	1,835,468 $116 Million
Q4 2020 Jan 26, 2021	BUY	$57.74 - $65.43 $14.7 Million - $16.6 Million	254,268 Added 15.4%	1,905,708 $118 Million
Q3 2020 Oct 20, 2020	SELL	$57.43 - $63.64 $10.9 Million - $12.1 Million	-190,219 Reduced 10.33%	1,651,440 $99.6 Million
Q2 2020 Jul 23, 2020	SELL	$54.82 - $64.09 $3.46 Million - $4.04 Million	-63,032 Reduced 3.31%	1,841,659 $108 Million
Q1 2020 Apr 20, 2020	BUY	$46.4 - $67.43 $11,275 - $16,385	243 Added 0.01%	1,904,691 $106 Million
Q4 2019 Jan 28, 2020	BUY	$49.21 - $64.19 $15.4 Million - $20.2 Million	313,920 Added 19.74%	1,904,448 $122 Million
Q3 2019 Oct 30, 2019	SELL	$42.77 - $50.71 $7.34 Million - $8.7 Million	-171,533 Reduced 9.73%	1,590,528 $80.7 Million
Q2 2019 Jul 09, 2019	BUY	$44.62 - $49.34 $5.69 Million - $6.3 Million	127,617 Added 7.81%	1,762,061 $79.9 Million
Q1 2019 Apr 15, 2019	BUY	$45.12 - $53.8 $6.58 Million - $7.85 Million	145,890 Added 9.8%	1,634,444 $78 Million
Q4 2018 Jan 10, 2019	BUY	$48.76 - $63.23 $35.9 Million - $46.5 Million	736,000 Added 97.8%	1,488,554 $77.4 Million
Q3 2018 Oct 24, 2018	SELL	$55.19 - $62.25 $803,290 - $906,048	-14,555 Reduced 1.9%	752,554 $46.7 Million
Q2 2018 Jul 17, 2018	SELL	$50.53 - $62.98 $646,986 - $806,395	-12,804 Reduced 1.64%	767,109 $42.5 Million
Q1 2018 Apr 27, 2018	SELL	$59.92 - $68.98 $794,119 - $914,191	-13,253 Reduced 1.67%	779,913 $49.3 Million
Q4 2017 Feb 08, 2018	SELL	$59.94 - $65.35 $27.4 Million - $29.9 Million	-457,451 Reduced 36.58%	793,166 $48.6 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $69.1 Million - $79.7 Million	1,250,617	1,250,617 $79.7 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Systems Of Alabama, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Systems Of Alabama with notifications on news.

Account

Retirement Systems Of Alabama Bristol Myers Squibb CO Transaction History